Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Recruiting
Observational Study
Heart; Dysfunction Postoperative, Cardiac Surgery
Genetic Predisposition to Disease
Atrial Fibrillation
Myocardial Infarction
Heart Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 4,000 (estimated)
- Sponsor
- Brigham and Women's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Undergoing heart surgery
* Willing to provide consent
Exclusion Criteria:
* Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Contacts
No contact information available.